Skip to content
Screener

AngioDynamics ANGO EV / EBITDA

EV / EBITDA at other companies

Abbott logo
AbbottABT
17.2×-6.0×
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
12.3×-6.5×
TFX
TeleflexTFX
29.2×+13.5×
Stryker logo
StrykerSYK
22.1×-11.8×
Merit Medical Systems logo
Merit Medical SystemsMMSI
14.2×-10.5×
ICU Medical logo
ICU MedicalICUI
17.1×+1.5×

Other financials

Income statement

See full
Revenue$86.6M+8.0%
Gross profit$46.8M+10.8%
Operating income-$10.2M-76.1%
Net income-$11.4M-88.5%
EPS (diluted)-$0.27-80.0%

Balance sheet

See full
Cash & equivalents$53.9M-3.6%
Total debt$11.0M+8.0%
Total equity$170.8M-6.6%
Total assets$267.2M-4.6%

Cash flow

See full
Operating cash flow$17.5M—
CapEx$413.0K-46.8%
Free cash flow$17.0M—

Valuation

See full
Market cap$648.51M+88.9%
Enterprise value$605.6M+103%
P/S2×+0.9×

Profitability

See full
Gross margin54.6%+0.7pp
Operating margin-12.5%-1.0pp
Net margin-11.5%-0.1pp
FCF margin0.2%—

Returns & leverage

See full
Return on equity-20.8%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.2×0.0×

Where this comes from

Calculated from AngioDynamics’s reported figures.

enterprise value/ebitda=9.7×

Based on the most recent quarter.

The source filing: AngioDynamics’s 10-Q, filed January 8, 2024. Open the filing →

Filed
Jan 8, 2024
Fiscal quarter
Q2 FY2024
Calendar quarter
Q4 2023
Accession
0001628280-24-000857

FAQ

What is AngioDynamics's EV / EBITDA?
AngioDynamics (ANGO) reported EV / EBITDA of 9.7× in Q3 2023.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Ask your AI about AngioDynamics's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude